TY - JOUR
T1 - Comparison of injection drug users accessing syringes from pharmacies, syringe exchange programs, and other syringe sources to inform targeted HIV prevention and intervention strategies
AU - Rudolph, Abby E.
AU - Crawford, Natalie D.
AU - Ompad, Danielle C.
AU - Benjamin, Ebele O.
AU - Stern, Rachel J.
AU - Fuller, Crystal M.
N1 - Funding Information:
Funding: National Institute on Drug Abuse (grant DA018061).
PY - 2010
Y1 - 2010
N2 - Objective: To describe injection drug users (IDUs) who access syringes through different outlets to help inform the prevention needs of IDUs who underuse safe syringe sources in New York City (NYC), where syringe availability is high compared with other U.S. cities. Design: Cross sectional. Setting: NYC, 2005-2007. Participants: 285 IDUs. Intervention: Participants were recruited using random street-intercept sampling in 36 socioeconomically disadvantaged neighborhoods. Main outcome measures: IDUs using syringe exchange programs (SEPs), pharmacies, or other outlets as a primary syringe source were compared based on sociodemographic characteristics, injection practices, and medical service use. Results: Chi-square tests and polytomous logistic regression were used to compare IDUs with different self-reported primary syringe sources used in the 6 months preceding study entry. Compared with IDUs using other syringe sources, those primarily using SEPs were less likely to be black (adjusted odds ratio 0.26 [95% CI 0.11-0.57]), more likely to inject daily (3.32 [1.58-6.98]), and more likely to inject with a new syringe (2.68 [1.30-5.54]). Compared with IDUs using other syringe sources, those primarily using pharmacies were less likely to be black (0.39 [0.17-0.90]). Conclusion: These data suggest that pharmacies and SEPs may be reaching different populations of IDUs and highlight a subpopulation of highly marginalized IDUs (i.e., black race, infrequent injectors) who are underusing safe syringe sources in NYC. Targeted interventions are needed to reduce racial disparities and increase use of safe syringe outlets.
AB - Objective: To describe injection drug users (IDUs) who access syringes through different outlets to help inform the prevention needs of IDUs who underuse safe syringe sources in New York City (NYC), where syringe availability is high compared with other U.S. cities. Design: Cross sectional. Setting: NYC, 2005-2007. Participants: 285 IDUs. Intervention: Participants were recruited using random street-intercept sampling in 36 socioeconomically disadvantaged neighborhoods. Main outcome measures: IDUs using syringe exchange programs (SEPs), pharmacies, or other outlets as a primary syringe source were compared based on sociodemographic characteristics, injection practices, and medical service use. Results: Chi-square tests and polytomous logistic regression were used to compare IDUs with different self-reported primary syringe sources used in the 6 months preceding study entry. Compared with IDUs using other syringe sources, those primarily using SEPs were less likely to be black (adjusted odds ratio 0.26 [95% CI 0.11-0.57]), more likely to inject daily (3.32 [1.58-6.98]), and more likely to inject with a new syringe (2.68 [1.30-5.54]). Compared with IDUs using other syringe sources, those primarily using pharmacies were less likely to be black (0.39 [0.17-0.90]). Conclusion: These data suggest that pharmacies and SEPs may be reaching different populations of IDUs and highlight a subpopulation of highly marginalized IDUs (i.e., black race, infrequent injectors) who are underusing safe syringe sources in NYC. Targeted interventions are needed to reduce racial disparities and increase use of safe syringe outlets.
KW - Human immunodeficiency virus
KW - Pharmacy services
KW - Race
KW - Syringe access
KW - Syringe exchange programs
UR - http://www.scopus.com/inward/record.url?scp=77952517172&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=77952517172&partnerID=8YFLogxK
U2 - 10.1331/JAPhA.2010.09193
DO - 10.1331/JAPhA.2010.09193
M3 - Article
C2 - 20199954
AN - SCOPUS:77952517172
SN - 1544-3191
VL - 50
SP - 140
EP - 147
JO - Journal of the American Pharmacists Association
JF - Journal of the American Pharmacists Association
IS - 2
ER -